Download the free whitepaper: Unravelling the complexities of genomics-driven drug discovery

Genomics-driven drug discovery holds immense promise in developing targeted therapies by leveraging genetic and biomarker information to understand the root causes of diseases. However, the field faces significant hurdles.

In this whitepaper, we examine the obstacles of limited recontactability, scarcity of multi-omics data sets, lack of diversity in data, and the challenge of scaling research for rare diseases. By addressing these challenges and proposing strategies to address them, this whitepaper aims to chart a path by which we can harness the full potential of genomics-driven drug discovery.

 

whitepaper image
download icon

Download report

The Sano site-enablement model

How Sano turns trial sites into a scalable source of qualified patients

Sano Genetics helps sponsors activate trial sites as a reliable, high-quality recruitment channel for genetically-targeted and complex studies. The site-enablement model is designed to surface feasibility and enrollment risk early, when adjustments can still be made.

This brief report reveals:
✅ The operational risks resulting from fragmentation across processes
✅ How Sano's site-enablement model integrates site activation, genetic testing, and patient engagement into a single execution layer
✅ What this approach enables for genetically-targeted and complex trials

Download now to learn more.

siteenablementmodelbanner-1